Read more

November 01, 2022
1 min read
Save

Distal cap-assisted endoscopic mucosal resection safe, effective for fibrotic polyps

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHARLOTTE, N.C. — Distal cap-assisted endoscopic mucosal resection is safe and effective for managing non-lifting and fibrotic colorectal polyps, according to a multicenter study presented at ACG 2022 Annual Scientific Meeting.

“Multiple interventions have been proposed for management of these polyps; however, each have limitations,” Scott R. Douglas, MD, from Penn State Health Milton S. Hershey Medical Center, and colleagues wrote.

Source: Adobe Stock.
Douglas and colleagues concluded that EMR-DC is “safe and efficacious” and that it “may offer several advantages over more expensive or invasive endoscopic techniques used for the indication.”
Source: Adobe Stock.

According to researchers, submucosal fibrosis is a common occurrence and may be caused by biopsy sampling, submucosal tattoo or previous ineffective polyp resection attempts. A developing technique for management of this condition is distal cap-assisted endoscopic mucosal resection (EMR-DC), in which tissue from adherent areas is suctioned through an open snare on a clear distal attachment cap fitted 3 to 4 mm from the colonoscope tip, and the cap is closed on the lesion. Electrocautery was used to transect the tissue.

In this retrospective study, three endoscopists performed EMR-DC in 61 patients (mean age, 66.8 years). The majority of cases (88.5%) had previously attempted polypectomies, followed by previous biopsy (4.9%), biopsy and tattoo (4.9%), and submucosal tattoo injection (1.6%). The average lesion size was 49 mm (range, 15-95 mm).

Researchers reported complete macroscopic resection in 100% of cases, with a low adenoma recurrence rate of 9.8% at 6 months. The procedure took an average 49.5 minutes to perform, and only two serious adverse events occurred: One patient experienced post-polypectomy syndrome and needed hospitalization, and one had a post-procedural bleeding that required repeat colonoscopy.

Douglas and colleagues concluded that EMR-DC is “safe and efficacious” and that it “may offer several advantages over more expensive or invasive endoscopic techniques used for the indication.”